cvs caremark semaglutide recently announced that Wegovy will become the preferred GLP-1 medication for obesity treatment starting in July, leaving many questions for those currently prescribed Zepbound and other obesity medications. OAC is Rx: Prescription Drug Benefits

This nucleocytoplasmic shuttling mechanism enables rapid transcriptional adaptation to metabolic stress

The Precision Peptide Genetic Test reveals predispositions in GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313variants that may help provide context for how aggressively a patient's dose should be increased

Battle mentioned how global spending on skin lightening is projected to triple to 31.2 billion by 2024 with the biggest markets in East Asia, Asia Pacific, and Africa

Data from the meta-analysis by Elkin et al

2013;126(10):925e1122

Gastrointestinal-renal axis: role in the regulation of blood pressure